FDA investigators issued a Form FDA 483 (FDA-483), Inspectional Observations. Key issues included failure to monitor critical sterilization temperatures, inadequate recording procedures for ...

Mumbai: Cipla has announced that the United States Food and Drugs Administration (USFDA) has concluded an inspection at the ...

The U.S. Food and Drug Administration has lifted a clinical hold on three cell therapies being developed by CARsgen ...

Drug maker Cipla on Wednesday said the US health regulator has issued eight observations after inspecting its Bengaluru-based ...

The FDA conducted an inspection at the manufacturing facility in Virgonagar from Nov. 7 to Nov. 13, according to an exchange ...

Hagens Berman urges investors in Humacyte, Inc. (NASDAQ: HUMA) who suffered substantial losses to submit your losses now .

Raichur: Shilpa Medicare has announced that the US Food and Drug Administration (USFDA) has issued Form 483 with four ...

On Friday, BTIG reaffirmed its Buy rating and $10.00 stock price target for Humacyte (NASDAQ:HUMA) following the release of a Form 483 from the FDA. The form, which details findings from facility ...

Vijayawada: The Andhra Sugars Limited has undergone US FDA inspection at their aspirin manufacturing facility at ...

Philadelphia, Pennsylvania-- (Newsfile Corp. - October 29, 2024) - Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Humacyte, Inc. ("Humacyte" or the ...